Skip to main content

RHUMBLINE ADVISERS

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in ESPR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$0
+$0 QoQ
Shares Held
305,675
+10.6% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 20% Shared 0% None 80%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. ESPR ranks #48 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 305,675
2026-03-31 276,401
2025-12-31 269,738
2025-09-30 277,491
2025-06-30 275,688
2025-03-31 236,030
2024-12-31 246,914
2024-09-30 243,090
2024-06-30 252,038
2024-03-31 3,784
2023-12-31 3,784
2023-09-30 3,784
2023-06-30 7,137
2023-03-31 99,651
2022-12-31 92,828
2022-09-30 85,612
2022-06-30 75,713
2022-03-31 53,717
2021-12-31 31,133
2021-09-30 31,612
2021-06-30 32,878
2021-03-31 32,071
2020-12-31 34,947
2020-09-30 33,999
2020-06-30 43,609
2020-03-31 38,147